Companies that successfully shepherd their discoveries to the marketplace need to have certain skill sets and abilities, Chizzo said, from adapting through internal cultural shifts as the company progresses to raising enough money for clinical trials and intellectual property protections.
“You’re always kind of changing the wheels on the bus as you’re going down the highway,” Chizzo said.
Young biotech companies these days are having a tougher time than their predecessors, according to a June 14 report from Ernst & Young, which found that startups are getting an ever-smaller piece of investment pie.
To read the full, original article click on this link: Moving Life Sciences Cos. Beyond Incubation | Worcester Business Journal
Author: Matt Pilon
